LETROZOLE DEXCEL

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

LETROZOLE

متاح من:

DEXCEL LTD, ISRAEL

ATC رمز:

L02BG04

الشكل الصيدلاني:

FILM COATED TABLETS

تركيب:

LETROZOLE 2.5 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

HAUPT PHARMA MUNSTER GmbH, GERMANY

المجموعة العلاجية:

LETROZOLE

المجال العلاجي:

LETROZOLE

الخصائص العلاجية:

Letrozole - Dexcel tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whome hormone receptor status cannot be determined locally advanced or metastatic breast cancer. Letrozole - Dexcel is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

تاريخ الترخيص:

2016-02-29